Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by informatique.ircm
Group name EQUIPEFC
Item Type Journal Article
Title The mouse HP1 proteins are not required for cell viability but are essential for preventing liver tumorigenesis
Creator Saksouk et al.
Author Nehmé Saksouk
Author Shefqet Hajdari
Author Marine Pratlong
Author Célia Barrachina
Author Aliki Zavoriti
Author Amélie Sarrazin
Author Nelly Pirot
Author Jean-Yohan Noël
Author Lakhdar Khellaf
Author Eric Fabbrizio
Author Florence M. Cammas
Abstract Chromatin organization plays essential roles in cell identity and functions. Here, we demonstrated by hepatocyte-specific inactivation of the genes encoding the three Heterochromatin Protein 1 (HP1?, ? and ?) in mice (HP1-TKO) that these proteins are dispensable for hepatocyte activity and survival. Conversely, the chronic absence of these proteins led to a drastic increased incidence of liver tumor development. Molecular characterization of HP1-TKO hepatocytes revealed that HP1 proteins are required for maintenance of histone marks associated with heterochromatin, and for the appropriate expression of large number of genes involved in liver-specific functions as well as in genes encoding for transcriptional repressors of the KRAB-ZFP family. Moreover, several specific endogenous retrovirus families were upregulated in HP1-TKO hepatocytes, leading to the deregulated expression of genes in their vicinity. Our findings indicate that HP1 proteins act as guardians of liver homeostasis to prevent tumor development through the modulation of multiple chromatin-associated events.
Publication bioRxiv
Pages 441279
Date janvier 1, 2018
DOI 10.1101/441279
URL http://biorxiv.org/content/early/2018/10/11/441279.abstract
Date Added 2019/12/19 - 15:57:10
Date Modified 2019/12/19 - 15:57:10


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés